0001628280-24-024944.txt : 20240523
0001628280-24-024944.hdr.sgml : 20240523
20240523161554
ACCESSION NUMBER: 0001628280-24-024944
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240521
FILED AS OF DATE: 20240523
DATE AS OF CHANGE: 20240523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Renz Justin A
CENTRAL INDEX KEY: 0001466562
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 24978431
MAIL ADDRESS:
STREET 1: C/O KARYOPHARM THERAPEUTICS INC.
STREET 2: 85 WELLS AVENUE, SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
4
1
wk-form4_1716495332.xml
FORM 4
X0508
4
2024-05-21
0
0001437402
ARDELYX, INC.
ARDX
0001466562
Renz Justin A
C/O ARDELYX, INC.
400 FIFTH AVENUE, SUITE 210
WALTHAM
MA
02451
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-05-21
4
S
0
5167
7.811
D
300546
D
Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
Reflects the adjusted total which includes the purchase of 878 shares under the Ardelyx Employee Stock Purchase Plan in February 2024.
/s/ Elizabeth Grammer, Attorney-in-Fact for Justin Renz
2024-05-23